Moreover, no significant changes in percentages of cells between stage I and stage II were observed, assuming that PD-L1+CD20+ % and PD-1+CD20+ % may not have major roles at primary DLBCL stages. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.